Login / Signup

Withdrawal of immunosuppressants and low-dose steroids in patients with stable IgG4-RD (WInS IgG4-RD): an investigator-initiated, multicentre, open-label, randomised controlled trial.

Linyi PengYuxue NieJiaxin ZhouLijun WuXiaomei ChenFang WangJieqiong LiYu PengHui LuLidan ZhaoMeng Tao LiYan ZhaoXiaofeng ZengYunyun FeiWen Zhang
Published in: Annals of the rheumatic diseases (2024)
NCT04124861.
Keyphrases
  • study protocol
  • open label
  • low dose
  • clinical trial
  • randomized controlled trial
  • high dose
  • phase ii
  • phase iii
  • phase ii study
  • double blind